46 / 112
44
WFSBP 2015
Scientific Programme
|
Tuesday, 16 June 2015
S-23-004
The effect of prolonged duration of untreated depression
on antidepressant treatment outcome
Lars Vedel Kessing, Denmark
T7: C
hildhood
& A
dolescent
D
isorders
: B
asic
/ C
linical
S-24
Symposium
11:00–12:30
Kokkali Room
Oxytocin and social cognition: From social attachment
and reward to novel treatments for autism
Chair:
Larry Young, USA
Co-Chair: Adam Guastella, Australia
S-24-001
Oxytocin and social attachment: Implications for novel
therapies for autism
Larry Young, USA
S-24-002
Interactions of oxytocin and serotonin in the striatum me-
diate social reward
Gul Dolen, USA
S-24-003
Common polymorphism in the oxytocin receptor gene
(OXTR) is associated with human social recognition skills
David Skuse, United Kingdom
E. Binder, J. Cubells, K. Conneely, I. Lee, A. Lori, L. Young,
T. Lehtimaki
S-24-004
Oxytocin therapies to treat core social impairments in au-
tism: Clinical treatment trials in toddlers and youth
Adam Guastella, Australia
T40: S
chizophrenia
: B
asic
/ C
linical
S-25
Symposium
11:00–12:30
Conference Room 1
Sleep, spindles, and schizophrenia
Chair:
Robert McCarley, USA
Co-Chair: Fabio Ferrarelli, USA
S-25-001
Sleep spindle deficits point to thalamic reticular nucleus
dysfunction in schizophrenia
Fabio Ferrarelli, USA
G. Tononi
S-25-002
Optogenetic studies of the role of the thalamic reticular
nucleus in spindles: Implications for schizophrenia
Robert McCarley, USA
J. McNally, J. McKenna, R. Strecker, F. Katsuki, R. Brown,
S. Thankachan
S-25-003
Sleep spindles, magnetic resonance spectroscopy in the
thalamus and cognitive functioning
Reto Huber, Switzerland
S-25-004
A mathematical model for a sleep spindle and its appli-
cation to the quantification of clozapine effects on sleep
spindles in schizophrenia
Periklis Ktonas, Greece
T23: N
euroimaging
: G
enetic
, F
unctional
, S
tructural
S-26
Symposium
15:00–16:30
Trianti Hall
Neuroimaging and risk for schizophrenia
Chair:
Lynn Delisi, USA
Co-Chair: Marek Kubicki, USA
S-26-001
Neuroimaging in people at ultra high risk for psychosis
Matthew Kempton, United Kingdom
J. van Os, L. Valmaggia, P. McGuire
S-26-002
Mechanisms underlying brain changes in early psychosis
Christos Pantelis, Australia
V. Cropley, M. Di Biase, S. Wood, A. Zalesky, A. R. Yung, D.
Velakoulis, B. Nelson, M. Yücel, A. Lin, L. Phillips, P. McGorry
S-26-003
Early childhood brain development in children at risk for
schizophrenia
John Gilmore, USA
S-26-004
New white matter biomarkers of schizophrenia risk
Marek Kubicki, USA
O. Pasternak, P. Savadjiev, L. Delisi, L. Seidman, M. Shenton